高级检索
当前位置: 首页 > 详情页

Differential analysis of sorting nexin 10 and sterol regulatory element-binding protein 2 expression in inflammatory bowel disease

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Yunnan Digest Dis Clin Med Ctr, Dept Gastroenterol,Affiliated Hosp, 157 Jingbi Rd, Kunming 650032, Yunnan, Peoples R China [2]Dali Bai Autonomous Prefecture Peoples Hosp, Dept Oncol, Dali 671000, Yunnan, Peoples R China [3]Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Yunnan Key Lab Innovat Applicat Tradit Chinese Med, Dept Gen Surg 2,Affiliated Hosp, 157 Jingbi Rd, Kunming 650032, Yunnan, Peoples R China
出处:
ISSN:

关键词: Sorting nexin 10 Sterol regulatory element-binding protein 2 Inflammatory bowel disease Pathogenesis

摘要:
Sorting nexin 10 (SNX10) expression induces intestinal barrier dysfunction and inflammatory responses; in contrast, its inhibition promotes intestinal mucosal healing through sterol regulatory element-binding protein 2 (SREBP2)-mediated cholesterol synthesis. However, its regulatory mechanism for the pathogenesis of inflammatory bowel disease (IBD) remains unclear. In this study, we examined SNX10 and SREBP2 expression in ulcerative colitis (UC) and Crohn's disease (CD). A total of 30 and 28 patients with UC and CD, respectively, were recruited. The expression of SNX10 and SREBP2 in the colonic mucosa was measured by immunohistochemistry (IHC). We discovered that patients with CD had significantly higher expression levels of SNX10 and SREBP2 than patients with UC and healthy controls. In addition, the expression of SREBP2 in patients with UC was significantly higher than that in healthy controls. In our study, we indicated that SNX10 and SREBP2 may serve as biomarkers for identifying patients with UC and CD, thereby providing a clinical therapeutic strategy for the treatment of IBD by inhibiting SNX10.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 免疫学
JCR分区:
出版当年[2023]版:
Q3 IMMUNOLOGY
最新[2023]版:
Q3 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Yunnan Digest Dis Clin Med Ctr, Dept Gastroenterol,Affiliated Hosp, 157 Jingbi Rd, Kunming 650032, Yunnan, Peoples R China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82325 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号